Old Web
English
Sign In
Acemap
>
authorDetail
>
Danna Chan
Danna Chan
Astex
Oncology
Internal medicine
Combination therapy
Medicine
Clinical endpoint
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I trial of DNA methyltransferase inhibitor guadecitabine combined with cisplatin and gemcitabine for solid malignancies including urothelial carcinoma (SPIRE).
2021
Clinical Cancer Research
Simon J. Crabb
Sarah Danson
James W.F. Catto
Syed A. Hussain
Danna Chan
Denise Dunkley
Nichola Downs
Ellice Marwood
Laura Day
Geoff N Saunders
Michelle Light
Amy Whitehead
Debbie J Ellis
Naveed Sarwar
Deborah Enting
Alison J. Birtle
Bernadette Johnson
Robert Huddart
Gareth Griffiths
Show All
Source
Cite
Save
Citations (2)
A Phase 1 Study Evaluating ASTX727 (decitabine and cedazuridine) and Venetoclax Combination Therapy in Newly Diagnosed AML Patients Unfit for Intensive Induction Chemotherapy
2021
Blood
Gabriel N. Mannis
Elizabeth A. Griffiths
Michael R. Savona
Olatoyosi Odenike
Gail J. Roboz
Casey OConnell
Jacqueline Dillingham
Prieya Wason
Lixia Zhu
Danna Chan
Harold N. Keer
Aram Oganesian
Kim-Hien Dao
Courtney D. DiNardo
Show All
Source
Cite
Save
Citations (0)
Abstract A072: Preliminary results of ASTX660, a novel non-peptidomimetic cIAP1/2 and XIAP antagonist, in 107 patients with solid tumors or lymphoma
2019
Molecular Cancer Therapeutics
Antoine Hollebecque
Sarit Assouline
Felipe Samaniego
Benoit You
Francine M. Foss
Anca Prica
Sarah W. Gordon
Marc Webster
Martin J. S. Dyer
Dima El Sharkawi
Geoffrey I. Shapiro
Lisa Nabell
Sarah P. Blagden
John Lister
Susanna Varkey Ulahannan
Yijun Sun
Danna Chan
Roberta Ferraldeschi
Monica M. Mita
Show All
Source
Cite
Save
Citations (1)
1